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Background: MiR-133a regulates cardiovascular cell development. However, its impact on vascular smooth muscle cell (VSMC) growth during 
atherosclerosis remains unclear. Galactosyltransferase 1-associating protein (GTAP), plays a role in stem cell growth. This study will analyze the role 
of miR-133a in regulation VSMC growth in atherosclerosis.
methods and results: VSMC cultured from the aorta of wild type (WT) and ApoE-/- mice. Both of ox-LDL and anti-miR-133a exerted inhibitory 
effects on WT and to a less extent, ApoE-/- VSMC growth. Compared to WT VSMC, the ApoE-/- cells expressed lower levels of miR-133a and insulin-
like growth factor-1 receptor (IGF-1R). Inhibition of miR-133a by anti-miR-133a decreased IGF-1R but increased GTAP (Fig.1), indicating that GTAP 
serves as a target of miR-133a. Western blot showed that IGF-1R was lower than those of untreated control while GTAP was increased by anti-
miR-133a. IGF-1R protein degradation was inhibited when GTAP was reduced by siRNA-GTAP. Moreover, miR-133a precursor decreased GTAP while 
increasing IGF-1R and IGF-1-driven VSMC growth. Down-regulation of miR-133a decreases IGF-1R and slow down VSMC growth. MiR-133a failed to 
regulate IGF-1R when GTAP was repressed by siRNA-GTAP.
conclusions: In atherosclerosis, miR-133a may serves as a positive regulator of IGF-1R and VSMC growth by targeting GTAP. Manipulation of the 
miR-133a/GTAP/IGF-1R pathway offers a new opportunity to control the effects of atherogenic factors on VSMC proliferation.
 
